Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.375 HKD | 0.00% | -5.06% | -18.48% |
03-26 | Mabpharm Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-10 | Livzon Pharma Recognizes Credit, Asset Impairments | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
198M | - | - | - | - | - | |
111B | ||||||
105B | ||||||
21.93B | - | |||||
22.34B | - | |||||
18.59B |
- Stock Market
- Equities
- 2181 Stock
- Charts Mabpharm Limited
- Sector Chart